Skip to content

PERNIX THERAPEUTICS HOLDINGS, INC.

Delisted

CIK 1024126fmd_0Y9GDTG1DDEJAFYYN8MCER7D6XManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2018, 35 periods

Latest annual · FY2017

Millions
Total revenues
146
Gross profit
101
Operating income
(56)
Net income
(77)
Free cash flow
(6)

Latest quarter · Q3 FY2018

Millions
Total revenues
37
Gross profit
25
Operating income
(11)
Net income
(12)
Free cash flow
(17)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2014 to FY2017
+6.3%
Revenue, 5 yearsFY2012 to FY2017
+19.0%
Net income, 5 yearsFY2012 to FY2017
n/m

PERNIX THERAPEUTICS HOLDINGS, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2017FY2016ChangeSource
Revenue$146.1 million$140.9 million+3.7%10-K 2018-03-08 · proof
Gross profit$101.4 million$97.5 million+4%10-K 2018-03-08 · proof
Operating income-$56.5 million-$140.3 million10-K 2018-03-08 · proof
Net income-$77.1 million-$169.6 million10-K 2018-03-08 · proof
Cash from operating activities-$5.9 million-$16.5 million10-K 2018-03-08 · proof
Free cash flow-$6 million-$17.5 million10-K 2018-03-08 · proof
Total assets$204 million$310.4 million-34.3%10-Q 2018-05-10 · proof
Total liabilities$378.3 million$424.5 million-10.9%10-Q 2018-05-10 · proof
Cash and cash equivalents$32.8 million$36.4 million-9.8%10-K 2018-03-08 · proof
Total debt$282.2 million$301.4 million-6.4%10-Q 2018-05-10 · proof
What was PERNIX THERAPEUTICS HOLDINGS, INC.'s revenue in fiscal 2017?
PERNIX THERAPEUTICS HOLDINGS, INC. reported revenue of $146.1 million for fiscal 2017 (the year ended Dec 31, 2017), against $140.9 million the year before (+3.7%). Source: the 10-K filed with the SEC on Mar 8, 2018. SEC
What was PERNIX THERAPEUTICS HOLDINGS, INC.'s gross profit in fiscal 2017?
PERNIX THERAPEUTICS HOLDINGS, INC. reported gross profit of $101.4 million for fiscal 2017 (the year ended Dec 31, 2017), against $97.5 million the year before (+4%). Source: the 10-K filed with the SEC on Mar 8, 2018. SEC
What was PERNIX THERAPEUTICS HOLDINGS, INC.'s operating income in fiscal 2017?
PERNIX THERAPEUTICS HOLDINGS, INC. reported operating income of -$56.5 million for fiscal 2017 (the year ended Dec 31, 2017), against -$140.3 million the year before. Source: the 10-K filed with the SEC on Mar 8, 2018. SEC
What was PERNIX THERAPEUTICS HOLDINGS, INC.'s net income in fiscal 2017?
PERNIX THERAPEUTICS HOLDINGS, INC. reported net income of -$77.1 million for fiscal 2017 (the year ended Dec 31, 2017), against -$169.6 million the year before. Source: the 10-K filed with the SEC on Mar 8, 2018. SEC
What was PERNIX THERAPEUTICS HOLDINGS, INC.'s cash from operating activities in fiscal 2017?
PERNIX THERAPEUTICS HOLDINGS, INC. reported cash from operating activities of -$5.9 million for fiscal 2017 (the year ended Dec 31, 2017), against -$16.5 million the year before. Source: the 10-K filed with the SEC on Mar 8, 2018. SEC
What was PERNIX THERAPEUTICS HOLDINGS, INC.'s free cash flow in fiscal 2017?
PERNIX THERAPEUTICS HOLDINGS, INC. reported free cash flow of -$6 million for fiscal 2017 (the year ended Dec 31, 2017), against -$17.5 million the year before. Source: the 10-K filed with the SEC on Mar 8, 2018. SEC
What are PERNIX THERAPEUTICS HOLDINGS, INC.'s total assets?
As of Dec 31, 2017, PERNIX THERAPEUTICS HOLDINGS, INC. reported total assets of $204 million, against $310.4 million a year earlier (-34.3%). Source: the 10-Q filed with the SEC on May 10, 2018 (restated). SEC
What are PERNIX THERAPEUTICS HOLDINGS, INC.'s total liabilities?
As of Dec 31, 2017, PERNIX THERAPEUTICS HOLDINGS, INC. reported total liabilities of $378.3 million, against $424.5 million a year earlier (-10.9%). Source: the 10-Q filed with the SEC on May 10, 2018 (restated). SEC
What are PERNIX THERAPEUTICS HOLDINGS, INC.'s cash and cash equivalents?
As of Dec 31, 2017, PERNIX THERAPEUTICS HOLDINGS, INC. reported cash and cash equivalents of $32.8 million, against $36.4 million a year earlier (-9.8%). Source: the 10-K filed with the SEC on Mar 8, 2018. SEC
What is PERNIX THERAPEUTICS HOLDINGS, INC.'s total debt?
As of Dec 31, 2017, PERNIX THERAPEUTICS HOLDINGS, INC. reported total debt of $282.2 million, against $301.4 million a year earlier (-6.4%). Source: the 10-Q filed with the SEC on May 10, 2018 (restated). SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1024126&period_type=annual&limit=5"

Information only, not investment advice.